FDA approves first generic Effexor extended release capsules for major depressive disorder

Share this content:
FDA approves first generic Effexor extended release capsules for major depressive disorder
FDA approves first generic Effexor extended release capsules for major depressive disorder
The Food and Drug Administration has approved the first generic version of Effexor XR capsules (venlafaxine hydrochloride) to treat major depressive disorder. Venlafaxine hydrochloride extended-release capsules in 37.5 milligram, 75 milligram and 150 milligram strengths have been approved to be manufactured by TEVA Pharmaceuticals.
http://www.fda.gov/